THCT (THC Therapeutics) Short-Term Debt: $0.73 Mil (As of Jul. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is THC Therapeutics Short-Term Debt?

THC Therapeutics THCT Short-Term Debt is $0.73 Mil as of Jul. 2024.

THC Therapeutics's Short-Term Debt for the quarter that ended in Jul. 2024 was $0.73 Mil.

THC Therapeutics's quarterly Short-Term Debt stayed the same from Jan. 2024 ($0.73 Mil) to Apr. 2024 ($0.73 Mil) and stayed the same from Apr. 2024 ($0.73 Mil) to Jul. 2024 ($0.73 Mil).

THC Therapeutics's annual Short-Term Debt declined from Jul. 2022 ($0.80 Mil) to Jul. 2023 ($0.73 Mil) but then stayed the same from Jul. 2023 ($0.73 Mil) to Jul. 2024 ($0.73 Mil).

THC Therapeutics Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

THC Therapeutics Short-Term Debt Related Terms

THC Therapeutics Short-Term Debt Historical Data

* Premium members only.

The historical data trend for THC Therapeutics's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

THC Therapeutics Short-Term Debt Chart

THC Therapeutics Annual Data
Trend Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.43 0.76 0.80 0.73 0.73

THC Therapeutics Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.73 0.73 0.73 0.73 0.73
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $0.73 Mil mean?
THC Therapeutics (THCT) has a Short-Term Debt of $0.73 Mil as of Jul. 2024.
Is THC Therapeutics' Short-Term Debt too high?
THC Therapeutics' current Short-Term Debt is $0.73 Mil.
How does THC Therapeutics' Short-Term Debt compare to ZTS and UTHR?
THC Therapeutics' Short-Term Debt of $0.73 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Drug Manufacturers company?
A good Short-Term Debt depends on the Drug Manufacturers industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. THC Therapeutics's current Short-Term Debt is $0.73 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is THC Therapeutics stock overvalued right now?
THC Therapeutics (THCT) has a current Short-Term Debt of $0.73 Mil. The current Short-Term Debt is $0.73 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For THC Therapeutics (THCT), the current Short-Term Debt is $0.73 Mil as of Jul. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

THC Therapeutics Business Description

Address 203 S Church Steet, Jacksboro, TX, USA, 76458
Website https://thct.io
THC Therapeutics Inc is a United States-based company. It is focused on developing a sanitizing herb dryer, the dHydronator, which has been specifically designed for the drying and sanitizing i.e., reducing the bacterial count of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The main function of the dHydronator is to accelerate the drying time of an herb while sanitizing it. The dHydronator can be used to dry a variety of herbs, and it has been specifically tested for use with cannabis.